Accordingly, oxidative stress triggers STAT3 activation in several cell types (106–108), and ROS are involved in EGF-induced STAT3 phosphorylation in prostate cancer (33), leading to increased pro-tumorigenic action. The gene discussed is STAT3; the disease is prostate carcinoma.